LMR Partners’s Anavex Life Sciences AVXL Stock Holding History

LMR Partners’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-121,705	Closed	-$319K	–	362
2018 Q2	$319K	Buy	+121,705	New	+$340K	0.02%	339

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LMR Partners's AVXL Position: Q3 2018 in Review

LMR Partners sold out of Anavex Life Sciences (AVXL) in Q3 2018, closing a stake of 121,705 shares — an estimated $319K sold.

LMR Partners first reported a position in AVXL in Q2 2018 and held it in 1 quarter. The position peaked at $319K in Q2 2018. 48 funds tracked by Wall St. Rank hold AVXL as of Q3 2018.

LMR Partners reported no remaining Anavex Life Sciences position as of Q3 2018 after selling out during the quarter.
LMR Partners sold 121,705 Anavex Life Sciences shares in Q3 2018, an estimated $319K.
LMR Partners first reported a position in Anavex Life Sciences in Q2 2018 and held it in 1 quarter.
LMR Partners's Anavex Life Sciences position peaked at $319K in Q2 2018.
48 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2018.

Based on LMR Partners's 13F filing for Q3 2018, filed 14 Nov 2018.